Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ADA 2026 5 - 8 June 2026

Improved treatment satisfaction with once-weekly IcoSema versus once-daily glargine U100 in insulin-naive adults with T2D (COMBINE 4)

Authors :

Liming Chen¹; Malik Benamar²; Benjamin Hilligsøe Harvey³; Sin Gon Kim⁴; Laura Pletsch-Borba²; Paolo Fiorina⁵

Affiliations

View Details Hide Details

Download .PDF

Keywords

Diabetes

Congress poster

Amylin

IcoSema (Icodec Semaglutide)

PHASE 3 (RCT)